Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · IEX Real-Time Price · USD
5.35
-0.49 (-8.39%)
At close: Mar 28, 2024, 4:00 PM
5.40
+0.05 (0.93%)
After-hours: Mar 28, 2024, 7:47 PM EDT

Syros Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Net Income
-164.57-94.65-86.56-84.04-75.44-62.28-54.01-51.42-34.75-15.64
Depreciation & Amortization
2.332.973.023.042.721.61.531.270.60.26
Share-Based Compensation
10.4311.4110.3510.949.846.614.424.233.230.94
Other Operating Activities
42.11-42.79-26.3512.72.6213.753.341.72.950.27
Operating Cash Flow
-109.71-123.07-99.54-57.36-60.25-40.32-44.73-40.54-23.03-11.97
Capital Expenditures
1.29-1.24-1.25-3.34-12.53-1.38-0.82-2.32-1.18-0.2
Change in Investments
36.0568.43-51.41500.79-9.27-14.77-25.0200
Investing Cash Flow
37.3467.19-52.6546.66-11.73-10.64-15.59-27.34-1.18-0.2
Share Issuance / Repurchase
43.53119.970.82103.7861.5669.1334.1150.88-0.230.02
Debt Issued / Paid
-0.07-0.59-0.2739.38-0.21-0.05-0.17-0.14-0.050
Other Financing Activities
-11.74-0.04-0.214.64--39.81-68.75
Financing Cash Flow
43.46131.0570.51142.9565.9969.0833.9490.56-0.2868.76
Net Cash Flow
-28.9175.17-81.68132.25-618.13-26.3822.68-24.4856.59
Free Cash Flow
-108.42-124.31-100.79-60.7-72.78-41.69-45.55-42.86-24.21-12.17
Free Cash Flow Margin
-1091.17%-835.39%-429.09%-402.17%-3672.10%-2033.66%-4137.15%-13519.87%-7635.96%-
Free Cash Flow Per Share
-3.83-9.84-16.12-13.18-18.09-12.77-17.93-33.76-122.23-79.80
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).